Advertisement

Table of Contents

April 01, 1996; Volume 49,Issue 4

You have access
Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.
R Bleakman, D D Schoepp, B Ballyk, H Bufton, E F Sharpe, K Thomas, P L Ornstein and R K Kamboj

Molecular Pharmacology April 1996, 49 (4) 581-585;
You have access
Metabotropic and ionotropic transducers of glutamate signal inversely control cytoplasmic Ca2+ concentration and excitotoxicity in cultured cerebellar granule cells: pivotal role of protein kinase C.
M Pizzi, P Galli, O Consolandi, V Arrighi, M Memo and P F Spano

Molecular Pharmacology April 1996, 49 (4) 586-594;
You have access
Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.
L L Shu and P J Houghton

Molecular Pharmacology April 1996, 49 (4) 595-601;
You have access
Suramin analogues as subtype-selective G protein inhibitors.
M Freissmuth, S Boehm, W Beindl, P Nickel, A P Ijzerman, M Hohenegger and C Nanoff

Molecular Pharmacology April 1996, 49 (4) 602-611;
You have access
Modulation of glucocorticoid-inducible gene expression by metal ions.
Y Makino, H Tanaka, K Dahlman-Wright and I Makino

Molecular Pharmacology April 1996, 49 (4) 612-620;
You have access
Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
A Mazumder, N Neamati, J P Sommadossi, G Gosselin, R F Schinazi, J L Imbach and Y Pommier

Molecular Pharmacology April 1996, 49 (4) 621-628;
You have access
Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C.
J Rousell, E B Haddad, J C Mak, B L Webb, M A Giembycz and P J Barnes

Molecular Pharmacology April 1996, 49 (4) 629-635;
You have access
Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
H E Nye and E J Nestler

Molecular Pharmacology April 1996, 49 (4) 636-645;
You have access
Thyrotropin-releasing hormone-induced subcellular redistribution and down-regulation of G11alpha: analysis of agonist regulation of coexpressed G11alpha species variants.
P Svoboda, G D Kim, M A Grassie, K A Eidne and G Milligan

Molecular Pharmacology April 1996, 49 (4) 646-655;
You have access
D2, D3, and D4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes.
P Werner, N Hussy, G Buell, K A Jones and R A North

Molecular Pharmacology April 1996, 49 (4) 656-661;
You have access
Modulation of the inwardly rectifying potassium channel IRK1 by the m1 muscarinic receptor.
S V Jones

Molecular Pharmacology April 1996, 49 (4) 662-667;
You have access
Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells.
D Separovic, M Kester and P Ernsberger

Molecular Pharmacology April 1996, 49 (4) 668-675;
You have access
Isolation of N-vinylprotoporphyrin IX after hepatic cytochrome P450 inactivation by 3-[(arylthio)ethyl]sydnone in chick embryos pretreated with phenobarbital, glutethimide, dexamethasone, and beta-naphthoflavone: differential inhibition of ferrochelatase by N-vinylprotoporphyrin regioisomers.
S M Kimmett, R A Whitney and G S Marks

Molecular Pharmacology April 1996, 49 (4) 676-682;
You have access
Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
J Kim, Q Jiang, M Glashofer, S Yehle, J Wess and K A Jacobson

Molecular Pharmacology April 1996, 49 (4) 683-691;
You have access
Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice.
J A Javitch, D Fu and J Chen

Molecular Pharmacology April 1996, 49 (4) 692-698;
You have access
Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.
M A Riva, R Molteni, E Lovati, F Fumagalli, M Rusnati and G Racagni

Molecular Pharmacology April 1996, 49 (4) 699-706;
You have access
Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system.
X Pan, S R Ikeda and D L Lewis

Molecular Pharmacology April 1996, 49 (4) 707-714;
You have access
Ciclazindol inhibits ATP-sensitive K+ channels and stimulates insulin secretion in CR1-G1 insulin-secreting cells.
K Lee, R N Khan, I C Rowe, S E Ozanne, A C Hall, E Papadakis, C N Hales and M L Ashford

Molecular Pharmacology April 1996, 49 (4) 715-720;
You have access
Activities of novel nonglycosidic epipodophyllotoxins in etoposide-sensitive and -resistant variants of human KB cells, P-388 cells, and in vivo multidrug-resistant murine leukemia cells.
I O Anyanwutaku, X Guo, H X Chen, Z Ji, K H Lee and Y C Cheng

Molecular Pharmacology April 1996, 49 (4) 721-726;
You have access
Unusual steroid specificity of the cell surface progesterone receptor on human sperm.
P F Blackmore, J F Fisher, C H Spilman and J E Bleasdale

Molecular Pharmacology April 1996, 49 (4) 727-739;
You have access
Ortho-substituted polychlorinated biphenyls alter calcium regulation by a ryanodine receptor-mediated mechanism: structural specificity toward skeletal- and cardiac-type microsomal calcium release channels.
P W Wong and I N Pessah

Molecular Pharmacology April 1996, 49 (4) 740-751;
You have access
Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
G Rousseau, F Nantel and M Bouvier

Molecular Pharmacology April 1996, 49 (4) 752-760;